{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:24:20Z","timestamp":1791390260356,"version":"4.3.3"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":1324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvsvenous.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jvsv.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T02:08:25Z","timestamp":1612145305000},"page":"1077-1082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Management of lymphatic vascular malformations: A systematic review of the literature"],"prefix":"10.1016","volume":"9","author":[{"given":"Neil M.","family":"Kalwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley G.","family":"Rockson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2021.01.013_bib1","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jvsv.2021.01.013_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.sempedsurg.2014.07.002","article-title":"Lymphatic malformations: diagnosis and management","volume":"23","author":"Elluru","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/1539685041690436","article-title":"Lymphatic malformations","volume":"2","author":"Smith","year":"2004","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.otohns.2010.02.026","article-title":"Lymphatic malformations: review of current treatment","volume":"142","author":"Perkins","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cps.2010.08.006","article-title":"Management of lymphatic malformations","volume":"38","author":"Greene","year":"2011","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib6","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jpedsurg.2010.06.010","article-title":"OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations","volume":"45","author":"Ono","year":"2010","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib7","doi-asserted-by":"crossref","first-page":"e20154545","DOI":"10.1542\/peds.2015-4545","article-title":"Initial experience with propranolol treatment of lymphatic anomalies: a case series","volume":"138","author":"Wu","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jvsv.2021.01.013_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/lrb.2017.0062","article-title":"Treatment of lymphatic malformations with the mTOR inhibitor sirolimus: a systematic review","volume":"16","author":"Wiegand","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib9","first-page":"15","article-title":"Abnormal pulmonary lymphatic flow in patients with paediatric pulmonary lymphatic disorders: diagnosis and treatment","volume":"36","author":"Itkin","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jvsv.2021.01.013_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0007-1226(64)80039-4","article-title":"Cystic hygroma of the neck","volume":"17","author":"Broomhead","year":"1964","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00006534-198010000-00003","article-title":"Facial hamartomas in children: neurofibroma, lymphangioma, and hemangioma","volume":"66","author":"Grabb","year":"1980","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib12","doi-asserted-by":"crossref","first-page":"110013","DOI":"10.1016\/j.ijporl.2020.110013","article-title":"Surgical resection of macrocystic lymphatic malformations of the head and neck: short and long-term outcomes","volume":"134","author":"Bonilla-Velez","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.bjps.2009.11.019","article-title":"Surgical resection of vulva lymphoedema circumscriptum","volume":"63","author":"Vignes","year":"2010","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib14","first-page":"236","article-title":"Laparoscopic treatment of intraabdominal cystic lymphangioma","volume":"111","author":"T\u00e2rcoveanu","year":"2016","journal-title":"Chirurgia (Bucur)"},{"key":"10.1016\/j.jvsv.2021.01.013_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/SLE.0b013e31828b8810","article-title":"Endoscopic diagnosis and treatment of esophageal cavernous lymphangioma","volume":"23","author":"Zhao","year":"2013","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/j.jvsv.2021.01.013_bib16","first-page":"3878960","article-title":"Percutaneous lauromacrogol foam sclerotherapy for the treatment of acute airway compression caused by lymphatic malformations in infants","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jvsv.2021.01.013_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/lrb.2008.1004","article-title":"Percutaneous sclerotherapy of lymphatic malformations with doxycycline","volume":"6","author":"Burrows","year":"2008","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00247-012-2406-2","article-title":"Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy","volume":"42","author":"Shergill","year":"2012","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib19","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jvir.2016.08.012","article-title":"Doxycycline sclerotherapy is superior in the treatment of pediatric lymphatic malformations","volume":"27","author":"Thomas","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-2005-872922","article-title":"Local bleomycin injection in the treatment of lymphangioma","volume":"15","author":"Baskin","year":"2005","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.joms.2008.06.046","article-title":"Sclerotherapy of microcystic lymphatic malformations in oral and facial regions","volume":"67","author":"Bai","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib22","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jpedsurg.2009.12.014","article-title":"Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation","volume":"45","author":"Karavelio\u011flu","year":"2010","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0189-6725.93304","article-title":"Intralesional bleomycin and sodium tetradecyl sulphate for haemangiomas and lymphangiomas","volume":"9","author":"Harjai","year":"2012","journal-title":"Afr J Paediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/phleb.2011.011082","article-title":"Intralesional injection of pingyangmycin is a safe and effective treatment for microcystic lymphatic malformations in the tongue","volume":"28","author":"Mai","year":"2013","journal-title":"Phlebology"},{"key":"10.1016\/j.jvsv.2021.01.013_bib25","first-page":"396","article-title":"Intralesional bleomycin sclerotherapy in childhood lymphangioma","volume":"55","author":"Erik\u00e7i","year":"2013","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jvsv.2021.01.013_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jpedsurg.2014.12.011","article-title":"Management of periorbital microcystic lymphatic malformation with blepharoptosis: surgical treatment combined with intralesional bleomycin injection","volume":"50","author":"Yang","year":"2015","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00383-020-04715-y","article-title":"Lymphatic malformations compromising the upper airway in children: ultrasound-guided intralesional focal sclerotherapy with bleomycin targeting culprit lesions","volume":"36","author":"Usui","year":"2020","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jvsv.2021.01.013_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcms.2012.10.022","article-title":"Pingyangmycin with triamcinolone acetonide effective for treatment of lymphatic malformations in the oral and maxillofacial region","volume":"41","author":"Luo","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5876(02)00117-9","article-title":"OK-432 therapy for lymphatic malformation in 32 patients (28 children)","volume":"65","author":"Claesson","year":"2002","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archotol.128.10.1137","article-title":"Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial","volume":"128","author":"Gigu\u00e8re","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1445-1433.2004.03115.x","article-title":"OK-432 and lymphatic malformations in children: the Starship Children's Hospital experience","volume":"74","author":"Wheeler","year":"2004","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/lary.20041","article-title":"Efficacy and safety of OK-432 immunotherapy of lymphatic malformations","volume":"119","author":"Smith","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvsv.2021.01.013_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/apa.13086","article-title":"Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes","volume":"104","author":"Ghaffarpour","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jvsv.2021.01.013_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0165-5876(03)00123-X","article-title":"Sclerotherapy for lymphangioma in children","volume":"67","author":"Sanlialp","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0003489414523561","article-title":"OK432 versus doxycycline for treatment of macrocystic lymphatic malformations","volume":"123","author":"Motz","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jvsv.2019.09.007","article-title":"Sclerotherapy for lymphatic malformations of head and neck: systematic review and meta-analysis","volume":"8","author":"De Maria","year":"2020","journal-title":"J\u00a0Vasc Surg Venous Lymphat Disord"},{"key":"10.1016\/j.jvsv.2021.01.013_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpedsurg.2006.10.012","article-title":"Treatment of lymphangioma in children: our experience of 128 cases","volume":"42","author":"Okazaki","year":"2007","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib38","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jpedsurg.2012.06.005","article-title":"Treatment of lymphatic malformations: a more conservative approach","volume":"47","author":"Gilony","year":"2012","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaoto.2013.5849","article-title":"Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations","volume":"140","author":"Balakrishnan","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.6061\/clinics\/2014(08)01","article-title":"Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children","volume":"69","author":"de Oliveira Ol\u00edmpio","year":"2014","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jvsv.2021.01.013_bib41","doi-asserted-by":"crossref","first-page":"109724","DOI":"10.1016\/j.ijporl.2019.109724","article-title":"Safety and efficacy of surgery combined with bleomycin irrigation for complex cervical-facial lymphatic malformations of children","volume":"128","author":"Wang","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib42","first-page":"790","article-title":"Treatment of lymphangioma circumscriptum with combined radiofrequency current and 900 nm diode laser","volume":"32","author":"Lapidoth","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jvir.2019.04.006","article-title":"Radiofrequency ablation of facial venolymphatic malformations: assessment of efficacy and safety and the role of injectable electrodes","volume":"31","author":"Cho","year":"2020","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/SAP.0000000000002049","article-title":"Long term follow-up of intralesional laser photocoagulation for head and neck lymphatic malformations using neodymium-yttrium-aluminum-garnet laser","volume":"84","author":"Chang","year":"2020","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib45","first-page":"380","article-title":"Thoracic duct embolization for the management of chylothoraces","volume":"19","author":"Nadolski","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jvsv.2021.01.013_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/j.tvir.2016.10.005","article-title":"Interventional treatment of pulmonary lymphatic anomalies","volume":"19","author":"Itkin","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0037-1604301","article-title":"Magnetic resonance lymphangiography and lymphatic embolization in the treatment of pulmonary complication of lymphatic malformation","volume":"34","author":"Itkin","year":"2017","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.229.61","article-title":"Propranolol as an alternative treatment option for pediatric lymphatic malformation","volume":"229","author":"Ozeki","year":"2013","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jvsv.2021.01.013_bib49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaad.2014.02.005","article-title":"An open-label study to evaluate sildenafil for the treatment of lymphatic malformations","volume":"70","author":"Danial","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib50","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijporl.2015.03.034","article-title":"Sildenafil for microcystic lymphatic malformations of the head and neck: a prospective study","volume":"79","author":"Koshy","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib51","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/00016489.2016.1272135","article-title":"Efficacy and safety of oral sildenafil in treatment of pediatric head and neck lymphatic malformations","volume":"137","author":"Wang","year":"2017","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib52","doi-asserted-by":"crossref","first-page":"e39558","DOI":"10.1371\/journal.pone.0039558","article-title":"Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis","volume":"7","author":"Coso","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jvsv.2021.01.013_bib53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hoc.2019.01.011","article-title":"Vascular anomalies: diagnosis of complicated anomalies and new medical treatment options","volume":"33","author":"Adams","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jvsv.2021.01.013_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002112","article-title":"Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis","volume":"71","author":"Huber","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jvsv.2021.01.013_bib55","doi-asserted-by":"crossref","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jvsv.2021.01.013_bib56","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jpedsurg.2019.12.021","article-title":"Effectiveness of sirolimus in the treatment of complex lymphatic malformations: single center report of 56 cases","volume":"55","author":"Tian","year":"2020","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jvsv.2021.01.013_bib57","doi-asserted-by":"crossref","first-page":"e20162105","DOI":"10.1542\/peds.2016-2105","article-title":"Microcystic lymphatic malformation successfully treated with topical rapamycin","volume":"139","author":"Garc\u00eda-Montero","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jvsv.2021.01.013_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/pde.13547","article-title":"Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: a case series","volume":"35","author":"Le Sage","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib59","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/pde.14104","article-title":"Treatment of superficial vascular anomalies with topical sirolimus: a multicenter case series","volume":"37","author":"Dodds","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jvsv.2021.01.013_bib60","doi-asserted-by":"crossref","first-page":"e27614","DOI":"10.1002\/pbc.27614","article-title":"Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease","volume":"66","author":"Ricci","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jvsv.2021.01.013_bib61","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/pbc.25278","article-title":"Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder","volume":"62","author":"Fernandes","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jvsv.2021.01.013_bib62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jvsv.2021.01.013_bib63","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/hmg\/ddy218","article-title":"Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly","volume":"27","author":"Li","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jvsv.2021.01.013_bib64","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41591-019-0479-2","article-title":"ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor","volume":"25","author":"Li","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jvsv.2021.01.013_bib65","doi-asserted-by":"crossref","first-page":"e27790","DOI":"10.1002\/pbc.27790","article-title":"Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis","volume":"66","author":"Boscolo","year":"2019","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X21000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X21000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:00:37Z","timestamp":1761980437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X21000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213333X21000731"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2021.01.013","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of lymphatic vascular malformations: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}